Steer Clear of Viberzi in Patients Who Don't Have a Gallbladder

FDA is now warning to avoid Viberzi (eluxadoline) in patients who don't have a gallbladder.

This is due to an increased risk of serious pancreatitis that can result in hospitalization or death in these patients.

You've likely seen ads promoting Viberzi for irritable bowel syndrome with diarrhea. It's an opioid agonist that works primarily in the gut at usual doses...similar to loperamide (Imodium A-D, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote